1.Dynamic evolution of research topics in the field of physical activity and executive function
Qing DENG ; Chen QIU ; Qingjun WANG ; Gui HUANG ; Yeting ZHANG
Chinese Journal of Tissue Engineering Research 2025;29(14):3043-3050
BACKGROUND:Research on physical activity and executive function continues to emerge,but no scholars have used visual tools to explore the dynamic evolution path of research topics in this field.OBJECTIVE:To explore the dynamic evolution process of research topics in the field of physical activity and executive function using bibliometrics methos,so as to clarify their development status and changes in knowledge structure.METHODS:The Web of Science database was searched by the search formula:TS=("Physical activity"AND"Executive function*")OR TS=(Exercise AND"Executive function*").According to the inclusion and exclusion criteria,4 386 relevant documents were selected as content,and SciMAT software was used for visual analysis.RESULTS AND CONCLUSION:The field of physical activity and executive function is booming,with more and more in-depth research and more room for future development.This field can be divided into four directions:executive function,children,the elderly,and intervention,and forms 11 main evolutionary paths.Topics such as"motor skills,""lifestyle,""aerobic exercise,"and"interventions"are likely to be the focus of future research,with the"adolescent"and"elderly"groups being the focus of research in this area.
2.Impact and clinical potential of RNA modifications in the development and progression of renal cancer
Huiting YANG ; Lu LU ; Qian LI ; Boyang LIU ; Shenglan GAO ; Bitang HUANG ; Chunlong YANG ; Qingjun PAN
Chinese Journal of Comparative Medicine 2025;35(7):128-147
Renal cancer is a common and increasingly prevalent malignancy with a complex pathogenesis influenced by genetics,smoking,and obesity.Current treatment mainly involves surgery with adjunctive chemotherapy,radiation,and immunotherapy,but high rates of recurrence and metastasis indicate its limited effectiveness,emphasizing the need for better therapeutic targets.Growing evidence indicates that epigenetic modifications,particularly RNA modifications,play a critical role in renal cancer development and progression.This review highlights recent advances in renal cancer epigenetics,focusing on RNA modifications such as N6-methyladenosine(m6 A),N7-methylguanosine(m7G),5-methylcytosine(m5C),N1-methyladenosine(m1A),adenosine-to-inosine(A-to-I),N6,2'-O-dimethyladenosine(m6Am),and N4-acetylcytidine(ac4C),along with their regulatory factors.It also explores the diagnostic and therapeutic potential of targeting RNA modifications and associated proteins.
3.Role and mechanism of m7G methylation modification in tumor drug resistance
Lu LU ; Huiting YANG ; Boyang LIU ; Qian LI ; Bitang HUANG ; Shenglan GAO ; Chunlong YANG ; Qingjun PAN
Chinese Journal of Comparative Medicine 2025;35(8):120-130
N7-methylguanosine(m7G)modification occurs at the 5'cap of mRNA in eukaryotes,and is also found at specific sites on tRNA and rRNA,showing wide conservation across various biological organisms.Aberrant m7G modification is involved in the dysregulation of gene expression and serves as a biomarker for multiple cancers,with significant potential for applications in tumor diagnosis and therapy.This review summarizes the biological functions and regulatory mechanisms of m7G modification,and outlines its potential clinical applications.It also highlights the oncogenic roles of aberrant m7G modification and its association with prognosis,providing a detailed discussion of the role and molecular mechanisms of abnormal m7G modification in regulating drug resistance in various cancers.
4.Impact and clinical potential of RNA modifications in the development and progression of renal cancer
Huiting YANG ; Lu LU ; Qian LI ; Boyang LIU ; Shenglan GAO ; Bitang HUANG ; Chunlong YANG ; Qingjun PAN
Chinese Journal of Comparative Medicine 2025;35(7):128-147
Renal cancer is a common and increasingly prevalent malignancy with a complex pathogenesis influenced by genetics,smoking,and obesity.Current treatment mainly involves surgery with adjunctive chemotherapy,radiation,and immunotherapy,but high rates of recurrence and metastasis indicate its limited effectiveness,emphasizing the need for better therapeutic targets.Growing evidence indicates that epigenetic modifications,particularly RNA modifications,play a critical role in renal cancer development and progression.This review highlights recent advances in renal cancer epigenetics,focusing on RNA modifications such as N6-methyladenosine(m6 A),N7-methylguanosine(m7G),5-methylcytosine(m5C),N1-methyladenosine(m1A),adenosine-to-inosine(A-to-I),N6,2'-O-dimethyladenosine(m6Am),and N4-acetylcytidine(ac4C),along with their regulatory factors.It also explores the diagnostic and therapeutic potential of targeting RNA modifications and associated proteins.
5.Role and mechanism of m7G methylation modification in tumor drug resistance
Lu LU ; Huiting YANG ; Boyang LIU ; Qian LI ; Bitang HUANG ; Shenglan GAO ; Chunlong YANG ; Qingjun PAN
Chinese Journal of Comparative Medicine 2025;35(8):120-130
N7-methylguanosine(m7G)modification occurs at the 5'cap of mRNA in eukaryotes,and is also found at specific sites on tRNA and rRNA,showing wide conservation across various biological organisms.Aberrant m7G modification is involved in the dysregulation of gene expression and serves as a biomarker for multiple cancers,with significant potential for applications in tumor diagnosis and therapy.This review summarizes the biological functions and regulatory mechanisms of m7G modification,and outlines its potential clinical applications.It also highlights the oncogenic roles of aberrant m7G modification and its association with prognosis,providing a detailed discussion of the role and molecular mechanisms of abnormal m7G modification in regulating drug resistance in various cancers.
6.Dynamic evolution of research topics in the field of physical activity and executive function
Qing DENG ; Chen QIU ; Qingjun WANG ; Gui HUANG ; Yeting ZHANG
Chinese Journal of Tissue Engineering Research 2025;29(14):3043-3050
BACKGROUND:Research on physical activity and executive function continues to emerge,but no scholars have used visual tools to explore the dynamic evolution path of research topics in this field.OBJECTIVE:To explore the dynamic evolution process of research topics in the field of physical activity and executive function using bibliometrics methos,so as to clarify their development status and changes in knowledge structure.METHODS:The Web of Science database was searched by the search formula:TS=("Physical activity"AND"Executive function*")OR TS=(Exercise AND"Executive function*").According to the inclusion and exclusion criteria,4 386 relevant documents were selected as content,and SciMAT software was used for visual analysis.RESULTS AND CONCLUSION:The field of physical activity and executive function is booming,with more and more in-depth research and more room for future development.This field can be divided into four directions:executive function,children,the elderly,and intervention,and forms 11 main evolutionary paths.Topics such as"motor skills,""lifestyle,""aerobic exercise,"and"interventions"are likely to be the focus of future research,with the"adolescent"and"elderly"groups being the focus of research in this area.
7.Epidemiological characteristics and spatio-temporal aggregation of scrub typhus in Hangzhou City from 2010 to 2022
Zhou SUN ; Yi WANG ; Qingjun KAO ; Renjie HUANG ; Xiaobin REN
Chinese Journal of Endemiology 2024;43(7):554-558
Objective:To study the epidemic characteristics and spatio-temporal distribution of scrub typhus in Hangzhou City.Methods:The case information of scrub typhus in Hangzhou City from 2010 to 2022 was collected through the Infectious Disease Surveillance and Reporting Information System of China Disease Prevention and Control Information System, and the incidence, time, population, and regional distribution characteristics of scrub typhus were analyzed. With street (township) as the unit, ArcGIS 10.2 software was used for global and local spatial autocorrelation analysis, SaTScan 10.1.2 software was used for spatio-temporal aggregation scanning.Results:From 2010 to 2022, a total of 362 cases were reported in Hangzhou City, with a median annual incidence of 0.260/100 000. The incidence showed a fluctuating upward trend year by year ( Z = 3.84, P < 0.001). The highest incidence was 0.528/100 000 in 2021 and the lowest incidence was 0.013/100 000 in 2010. The median time interval between onset and diagnosis was 7 days, ranging from 1 to 28 days. The peak incidence period was from September to November (52.49%, 190/362). There were 149 males (41.16%, 149/362) and 213 females (58.84%, 213/362). The age group of 60 - 69 years old had the highest number of cases, accounting for 32.32% (117/362). The majority of occupations were farmers (77.35%, 280/362). The top 3 regions with reported cases were Chun'an County (257 cases, 70.99%), Lin'an District (33 cases, 9.12%), and Jiande City (19 cases, 5.25%). Global spatial autocorrelation analysis showed that there was spatial aggregation in the incidence of scrub typhus in other years except 2015 - 2018 ( P < 0.05). Local spatial autocorrelation analysis showed that, except for 2015 and 2016, the incidence of scrub typhus in other years occurred in hot spots (high-high), which were all located in Chun'an County. The spatio-temporal aggregation analysis showed that the class Ⅰ cluster was centered around Jinfeng Township in Chun'an County, with a clustering period from December 2018 to November 2021, involving 22 townships. The class Ⅱ cluster was centered around Wanshi Township in Fuyang District, with a clustering period from December 2021 to November 2022, involving 14 streets (townships). Both of the two clusters were mountainous agricultural areas, with reported cases accounting for 38.67% (140/362). Conclusions:In Hangzhou City, the majority of scrub typhus cases are elderly female farmers, with a high incidence season in autumn, mainly occurring in agricultural areas in mountainous areas. It is recommended to carry out comprehensive prevention and control measures such as health education and personal protection for key populations, seasons and regions.
8.Evaluation of perioperative safety of lung surgery for patients with COVID-19
Wenxin TIAN ; Yaoguang SUN ; Qingjun WU ; Chao MA ; Peng JIAO ; Hanbo YU ; Chuan HUANG ; Donghang LI ; Yi TIAN ; Hongfeng TONG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(12):1753-1758
Objective To evaluate the perioperative safety of lung surgery for patients with corona virus disease 2019 (COVID-19). Methods We retrospectively analyzed the clinical data of the patients recovered from COVID-19 infection and received lung surgery from December 2022 to February 2023 in the Department of Thoracic Surgery at Beijing Hospital. Patients who received lung surgery and without COVID-19 at the same time were selected as a control group. Perioperative data between the two groups were compared. Results A total of 103 patients were included with 44 males and 49 females at an average age of (62.2±12.1) years. All surgeries were performed by uniportal video-assisted thoracoscopic surgery (VATS). Among patients who recovered from COVID-19, 53 (51.5%) received lobectomy, 30 (29.1%) received segmentectomy, and 20 (19.4%) received wedge resection. The interval between diagnosis of infection and lung surgery was ≤1 month in 32 (31.1%) patients, and >1 month in 71 (68.9%) patients. The results of virus nucleic acid test for all patients before surgery were negative. A total of 13 (12.6%) patients had positive IgM, and 100 (97.1%) patients had positive IgG. A total of 20 patients experienced perioperative complications (13 patients with pulmonary air leakage, 3 patients with chylothorax, 2 patients with atrial fibrillation, and 2 patients with severe pulmonary complications). There was one perioperative death. Comparing the patients who recovered from COVID-19 with those without COVID-19, we found no statistical difference in perioperative outcomes including surgical duration, postoperative drainage, duration of thoracic tube, and duration of postoperative stay (P>0.05). There was no significant difference in perioperative complications between the two groups (P>0.05). Multivariable logistical regression analysis demonstrated that positive IgM before surgery (OR=7.319, 95%CI 1.669 to 32.103, P=0.008), and longer duration of surgery (OR=1.016, 95%CI 1.003 to 1.028, P=0.013) were independent risk factors of perioperative complications for patients who recovered from COVID-19. Conclusion It is safe for patients recover from COVID-19 to receive lung surgery when symptoms disappear and the nucleic acid test turn negative. However, positive COVID-19 IgM is an independent risk factor for perioperative complications. We suggest that lung surgery could be performed when the nucleic acid test and COVID-19 IgM are both negative for patients recover from COVID-19 infection.
9.Safety evaluation of thymectomy in elderly patients aged 65 years and over
Peng JIAO ; Fanjuan WU ; Yuxing LIU ; Jiangyu WU ; Yaoguang SUN ; Wenxin TIAN ; Qingjun WU ; Chao MA ; Hanbo YU ; Chuan HUANG ; Donghang LI ; Hongfeng TONG
Chinese Journal of Geriatrics 2023;42(5):546-551
Objective:To evaluate the safety of thymic surgery in patients aged 65 years and over.Methods:A total of 696 patients who underwent thymectomy/thymoma resection in the Department of Thoracic Surgery of Beijing Hospital from November 2011 to March 2022 were collected and divided into two groups according to the age of 65 years old.The preoperative course of disease, MG stage, dosage of pyridostigmine bromide, American College of Anesthesiologists(ASA)score, surgical method, intraoperative bleeding, postoperative drainage, postoperative complications, Clavien-dindo score(CDC), and myasthenic crisis were recorded and statistically analyzed.Results:A total of 696 patients were enrolled, including 364 males and 332 females, aged 15~86 years, with an average age of 49.1 years.There were 309 patients with thymoma, 565 patients with MG, and 178 patients with both.There were 124 cases in the elderly group(≥65 years old)and 572 cases in the non-elderly group(<65 years old). The incidence of thymoma was higher in the elderly group(54.8 % versus 42.1 %, χ2=6.664, P=0.010), while the incidence of MG was lower(67.7 % versus 84.1 %, χ2=17.827, P<0.001). The ASA score of the elderly group was higher than that of the non-elderly group( χ2=52.372, P=0.000), and the preoperative ventilation function FEV1 and FEV1/FVC were also significantly lower than those of the non-elderly group( z=8.187, 4.580, P=0.000 for all). The drainage volume in the first 3 days after operation and postoperative drainage tube time in the elderly group were significantly higher than those in the non-elderly group( P=0.018, P=0.003). The incidence of postoperative myasthenia crisis in the elderly group was higher than that in the non-elderly group( P=0.034). There was no significant difference in the incidence of postoperative complications between the two groups, but after Clavien-dindo classification, the score of the elderly group was higher than that of the non-elderly group( P=0.003). Although the ASA score and Clavien-dindo score of the elderly group were both higher than those of the non-elderly group, there was no correlation between the two. Conclusions:Although the preoperative ASA score and pulmonary function of elderly patients were poorer than those in the non-elderly group, while the incidence of postoperative myasthenia crisis was higher, and the incidence of postoperative complications was not higher, the Clavien-dindo classification, however, was higher in elderly patients than that of the non-elderly group.After careful preoperative evaluation and strengthening perioperative management, most elderly patients can receive thymus surgery safely with acceptable risks.
10.Clinical characteristics in elderly patients with thymic epithelial tumors and prognostic analysis of more than 3 years postoperative follow-up
Peng JIAO ; Yaoguang SUN ; Fanjuan WU ; Wenxin TIAN ; Hanbo YU ; Chuan HUANG ; Qingjun WU ; Chao MA ; Hongfeng TONG
Chinese Journal of Geriatrics 2022;41(5):549-554
Objective:To evaluate the clinical characteristics and the surgical safety in patients aged 65 years and over with thymic epithelial tumor, and analyze the prognosis of 3-10 years postoperative tumor and myasthenia gravy.Methods:A total of 228 patients diagnosed as thymic tumor and undergoing surgical surgery to remove the tumor in Beijing Hospital from Jan.2011 to Dec.2018 were retrospectively enrolled.Patients were divided into a young(≤ 65 yrs)and old(>65 yrs)groups.The operation time, intra-operative bleeding, drainage volume in the first 3 days after operation, days with drainage tube after operation, postoperative days of hospital stays, the diameter of the tumors, pathological classification, Tumor-Node-Metastasis(TNM)staging, Masaoka-Koga staging, whether or not complicated with myasthenia gravis and complications were compared between two groups.The patients were followed up by outpatient or telephone, and recurrence of thymoma, survival status and improvement of myasthenia gravis were tracked.Results:There were significant differences in pathological classification between the two groups( P=0.002). The postoperative days with drainage tube were longer in patients≥65 years old than in patients<65 years old[4(2-17)days and 3(1-9), Z=2.316, P=0.021]. Thymic atrophy was more common in patients ≥ 65 years old than in patients <65 years old(10.2% and 1.7%, χ2=5.937, P=0.015). Incidence of thymoma plus myasthenia gravis were higher in patients aged <65 years than those aged ≥65years(68.2% vs.40.8%, χ2=12.240, P<0.001), and incidence of thymic hyperplasia were higher in patients aged <65 years than those aged ≥65years(58.1% and 38.8%, χ2=2.316, P=0.016). The recurrence of thymoma was a poor prognostic factor affecting the survival of patients.Meanwhile, Masaoka-Koga stage Ⅲ and Ⅳ and TNM stage Ⅲ and Ⅳ were independent risk factors for postoperative recurrence of thymoma. Conclusions:Thymectomy is safe and effective in the patients aged 65 and over, and may have a better long-term prognosis.

Result Analysis
Print
Save
E-mail